Creative and Compliant Commercial Communication Programming

Situation Analysis

  • The Company had a product to treat Gaucher’s Disease based on its proprietary plant-cell based technology for rare disease and entered into an in-licensing agreement with a biotherapeutics company
  • There was a global commercialization need for an alternative therapy to treat Gaucher’s Disease given the competitive supply issues (contamination)
  • The campaign objective was to develop an integrated, global pre- and post-launch commercialization and communications program that was compliant and creative for the situation

LaVoieHealthScience Solution

  • Developed a highly specialized and unique communications program focused on product needs, markets and patient access
  • Inserted an agency leader on commercial team for optimal cross-functional and partnership collaboration
  • Adjusted to partner needs as timeline and evolved key regulatory milestones
  • Executed regular media relations outreach, leadership media training and message development

Results

  • Implemented communications roll-out of pre-commercial launch plan
  • Created strategic counsel surrounding issues management, corporate reputation and competitive intelligence
  • Positioned high-profile media placements in national outlets including the New York Times, Wall Street Journal, Boston Globe, Washington Post, Forbes and BusinessWeek
  • Elevated The Company’s strategic initiative among internal stakeholders, analysts, advocacy groups and patients
  • Developed relationships with key stakeholders, leading up to FDA approval of the product
  • Established internal communications management, including strategic counsel, issues management counsel, collateral development and production material
  • B-Roll Video unbranded video footage/interview via an unrestricted educational grant for Gaucher educational video

Managed patient event in conjunction with third-party advocacy group

10